APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ivosidenib Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ivosidenib Drugs Market Outlook and Growth Opportunities 2026

22 December 2025196 pages

Choose your research edition.

Industry ResearchIvosidenib Drugs Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Ivosidenib Drugs Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Ivosidenib Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ivosidenib Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Ivosidenib Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Ivosidenib Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ivosidenib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ivosidenib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ivosidenib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ivosidenib Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ivosidenib Drugs market include Servier Pharmaceuticals. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ivosidenib Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ivosidenib Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ivosidenib Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ivosidenib Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Ivosidenib Drugs Segment by Company

Servier Pharmaceuticals

Ivosidenib Drugs Segment by Type

30 Tablets

60 Tablets

Ivosidenib Drugs Segment by Application

Hospital

Pharmacy

Ivosidenib Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ivosidenib Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ivosidenib Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ivosidenib Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Ivosidenib Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ivosidenib Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ivosidenib Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ivosidenib Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ivosidenib Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ivosidenib Drugs industry.

Chapter 3: Detailed analysis of Ivosidenib Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ivosidenib Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ivosidenib Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ivosidenib Drugs Industry Trends Table 2. Ivosidenib Drugs Industry Drivers Table 3. Ivosidenib Drugs Industry Opportunities and Challenges Table 4. Ivosidenib Drugs Industry Restraints Table 5. Global Ivosidenib Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ivosidenib Drugs Revenue Share by Company (2021-2026) Table 7. Global Ivosidenib Drugs Sales Volume by Company (units) & (2021-2026) Table 8. Global Ivosidenib Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Ivosidenib Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Ivosidenib Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ivosidenib Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Ivosidenib Drugs Company, Product Type & Application Table 13. Global Ivosidenib Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ivosidenib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 30 Tablets Table 18. Significant Companies of 60 Tablets Table 19. Global Ivosidenib Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (units) Table 20. Global Ivosidenib Drugs Sales Volume by Type (2021-2026) & (units) Table 21. Global Ivosidenib Drugs Sales Volume by Type (2027-2032) & (units) Table 22. Global Ivosidenib Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Ivosidenib Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Ivosidenib Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Ivosidenib Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Ivosidenib Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Ivosidenib Drugs Sales Value Share by Type (2021-2026) Table 28. Global Ivosidenib Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Pharmacy Table 31. Global Ivosidenib Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (units) Table 32. Global Ivosidenib Drugs Sales Volume by Application (2021-2026) & (units) Table 33. Global Ivosidenib Drugs Sales Volume by Application (2027-2032) & (units) Table 34. Global Ivosidenib Drugs Sales Volume Share by Application (2021-2026) Table 35. Global Ivosidenib Drugs Sales Volume Share by Application (2027-2032) Table 36. Global Ivosidenib Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Ivosidenib Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Ivosidenib Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Ivosidenib Drugs Sales Value Share by Application (2021-2026) Table 40. Global Ivosidenib Drugs Sales Value Share by Application (2027-2032) Table 41. Global Ivosidenib Drugs Sales by Region: 2021 VS 2025 VS 2032 (units) Table 42. Global Ivosidenib Drugs Sales by Region (2021-2026) & (units) Table 43. Global Ivosidenib Drugs Sales Market Share by Region (2021-2026) Table 44. Global Ivosidenib Drugs Sales by Region (2027-2032) & (units) Table 45. Global Ivosidenib Drugs Sales Market Share by Region (2027-2032) Table 46. Global Ivosidenib Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Ivosidenib Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Ivosidenib Drugs Sales Value Share by Region (2021-2026) Table 49. Global Ivosidenib Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Ivosidenib Drugs Sales Value Share by Region (2027-2032) Table 51. Global Ivosidenib Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Ivosidenib Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Ivosidenib Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Table 54. Global Ivosidenib Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Ivosidenib Drugs Sales by Country (2021-2026) & (units) Table 56. Global Ivosidenib Drugs Sales Market Share by Country (2021-2026) Table 57. Global Ivosidenib Drugs Sales by Country (2027-2032) & (units) Table 58. Global Ivosidenib Drugs Sales Market Share by Country (2027-2032) Table 59. Global Ivosidenib Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Ivosidenib Drugs Sales Value Market Share by Country (2021-2026) Table 61. Global Ivosidenib Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Ivosidenib Drugs Sales Value Market Share by Country (2027-2032) Table 63. Servier Pharmaceuticals Company Information Table 64. Servier Pharmaceuticals Business Overview Table 65. Servier Pharmaceuticals Ivosidenib Drugs Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Servier Pharmaceuticals Ivosidenib Drugs Product Portfolio Table 67. Servier Pharmaceuticals Recent Development Table 68. Key Raw Materials Table 69. Raw Materials Key Suppliers Table 70. Ivosidenib Drugs Distributors List Table 71. Ivosidenib Drugs Customers List Table 72. Research Programs/Design for This Report Table 73. Authors List of This Report Table 74. Secondary Sources Table 75. Primary Sources List of Figures Figure 1. Ivosidenib Drugs Product Image Figure 2. Global Ivosidenib Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ivosidenib Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ivosidenib Drugs Sales (2021-2032) & (units) Figure 5. Global Ivosidenib Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Ivosidenib Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 30 Tablets Image Figure 10. 60 Tablets Image Figure 11. Global Ivosidenib Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (units) Figure 12. Global Ivosidenib Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Ivosidenib Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Ivosidenib Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Ivosidenib Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Ivosidenib Drugs Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Pharmacy Image Figure 19. Global Ivosidenib Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (units) Figure 20. Global Ivosidenib Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Ivosidenib Drugs Sales Volume Share by Application (2021-2032) Figure 22. Global Ivosidenib Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Ivosidenib Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Ivosidenib Drugs Sales Value Share by Application (2021-2032) Figure 25. Global Ivosidenib Drugs Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 26. Global Ivosidenib Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Ivosidenib Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Ivosidenib Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Ivosidenib Drugs Sales Value (2021-2032) & (US$ Million) Figure 30. North America Ivosidenib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Ivosidenib Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Ivosidenib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Ivosidenib Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Ivosidenib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Ivosidenib Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. South America Ivosidenib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Ivosidenib Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Ivosidenib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Ivosidenib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Ivosidenib Drugs Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Ivosidenib Drugs Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 30 Tablets
  • 60 Tablets
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Servier Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ivosidenib Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Ivosidenib Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Ivosidenib Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ivosidenib Drugs Market Dynamics
  1. 2.1 Ivosidenib Drugs Industry Trends
  2. 2.2 Ivosidenib Drugs Industry Drivers
  3. 2.3 Ivosidenib Drugs Industry Opportunities and Challenges
  4. 2.4 Ivosidenib Drugs Industry Restraints
3 Ivosidenib Drugs Market by Company
  1. 3.1 Global Ivosidenib Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Ivosidenib Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Ivosidenib Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Ivosidenib Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Ivosidenib Drugs Company Ranking (2024-2026)
  6. 3.6 Global Ivosidenib Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Ivosidenib Drugs Company Product Type and Application
  8. 3.8 Global Ivosidenib Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ivosidenib Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ivosidenib Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ivosidenib Drugs Market by Type
  1. 4.1 Ivosidenib Drugs Type Introduction
  2. 4.1.1 30 Tablets
  3. 4.1.2 60 Tablets
  4. 4.2 Global Ivosidenib Drugs Sales Volume by Type
  5. 4.2.1 Global Ivosidenib Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ivosidenib Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Ivosidenib Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Ivosidenib Drugs Sales Value by Type
  9. 4.3.1 Global Ivosidenib Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Ivosidenib Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Ivosidenib Drugs Sales Value Share by Type (2021-2032)
5 Ivosidenib Drugs Market by Application
  1. 5.1 Ivosidenib Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.2 Global Ivosidenib Drugs Sales Volume by Application
  5. 5.2.1 Global Ivosidenib Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Ivosidenib Drugs Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Ivosidenib Drugs Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Ivosidenib Drugs Sales Value by Application
  9. 5.3.1 Global Ivosidenib Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Ivosidenib Drugs Sales Value by Application (2021-2032)
  11. 5.3.3 Global Ivosidenib Drugs Sales Value Share by Application (2021-2032)
6 Ivosidenib Drugs Regional Sales and Value Analysis
  1. 6.1 Global Ivosidenib Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ivosidenib Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Ivosidenib Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Ivosidenib Drugs Sales by Region (2027-2032)
  5. 6.3 Global Ivosidenib Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ivosidenib Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ivosidenib Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ivosidenib Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Ivosidenib Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ivosidenib Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Ivosidenib Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ivosidenib Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Ivosidenib Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ivosidenib Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ivosidenib Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ivosidenib Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Ivosidenib Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ivosidenib Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ivosidenib Drugs Sales Value Share by Country, 2025 VS 2032
7 Ivosidenib Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Ivosidenib Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ivosidenib Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ivosidenib Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Ivosidenib Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Ivosidenib Drugs Sales by Country (2027-2032)
  6. 7.4 Global Ivosidenib Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ivosidenib Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ivosidenib Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ivosidenib Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ivosidenib Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ivosidenib Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Servier Pharmaceuticals
  2. 8.1.1 Servier Pharmaceuticals Company Information
  3. 8.1.2 Servier Pharmaceuticals Business Overview
  4. 8.1.3 Servier Pharmaceuticals Ivosidenib Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Servier Pharmaceuticals Ivosidenib Drugs Product Portfolio
  6. 8.1.5 Servier Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ivosidenib Drugs Value Chain Analysis
  2. 9.1.1 Ivosidenib Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ivosidenib Drugs Sales Mode & Process
  6. 9.2 Ivosidenib Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ivosidenib Drugs Distributors
  9. 9.2.3 Ivosidenib Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst